Cowen Starts Avalanche Biotechnologies (AAVL) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
Go back to Cowen Starts Avalanche Biotechnologies (AAVL) at Outperform
August 25, 2014 7:12 AM EDT
William Blair initiated coverage on Avalanche Biotechnologies (NASDAQ: AAVL) with an Outperform rating.
For an analyst ratings summary and ratings history on Avalanche Biotechnologies click here. For more ratings news on Avalanche Biotechnologies click here.
Shares of Avalanche Biotechnologies closed at $30.52 yesterday.
...
More
August 25, 2014 6:55 AM EDT
Jefferies initiates coverage on July IPO Avalanche Biotechnologies (NASDAQ: AAVL) with a Buy rating and a price target of $40.00.
Analyst Biren Amin said, "AAVL shares hold significant promise based on PI data with AVA-101 observing meaningful VA improvements and durable responses in wAMD... More
August 25, 2014 6:53 AM EDT
Piper Jaffray initiates coverage on July IPO Avalanche Biotechnologies (NASDAQ: AAVL) with a Overweight rating and a price target of $39.00.
Analyst Joshua Schimmer comments, "The company is among a handful of pioneers in the gene therapy field, and a leader among an even... More
